XP Chemistries reported lower sales and losses for Q3 2024 but improved operating results year-over-year. Regulatory approval for its capsaicin feed additive is delayed to early 2025, with new financing secured through warrant exercises.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.